Hamzah Abu‐Sbeih
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Neutropenia and Cancer Infections
- Gastroenterology top 5%
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 43
- Colorectal Cancer Treatments and Studies 27
- Neutropenia and Cancer Infections 10
- Pancreatic and Hepatic Oncology Research 7
- Epidemiology 32
- Microscopic Colitis 24
- Co-authors
- Yinghong Wang (63 shared papers)Faisal S. Ali (24 shared papers)Wei Qiao (12 shared papers)Gottumukkala S. Raju (15 shared papers)Wenyi Luo (11 shared papers)David M. Richards (9 shared papers)Adi Diab (6 shared papers)Phillip Lum (11 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)The American Journal of Gastroenterology (9 papers)Journal for ImmunoTherapy of Cancer (9 papers)Gastroenterology (8 papers)Inflammatory Bowel Diseases (5 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Hamzah Abu‐Sbeih
69 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 74
- Oncology 1.6k
- Gastroenterology 108
- Epidemiology 673
- Immunology 387
- Hepatology 125
Countries citing papers authored by Hamzah Abu‐Sbeih
This map shows the geographic impact of Hamzah Abu‐Sbeih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamzah Abu‐Sbeih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamzah Abu‐Sbeih more than expected).
Fields of papers citing papers by Hamzah Abu‐Sbeih
This network shows the impact of papers produced by Hamzah Abu‐Sbeih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamzah Abu‐Sbeih. The network helps show where Hamzah Abu‐Sbeih may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamzah Abu‐Sbeih, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 184 | |
| 2 | 2018 | 178 | |
| 3 | 2018 | 163 | |
| 4 | 2019 | 149 | |
| 5 | 2018 | 147 | |
| 6 | 2019 | 142 | |
| 7 | 2019 | 108 | |
| 8 | 2019 | 84 | |
| 9 | 2019 | 67 | |
| 10 | 2019 | 63 | |
| 11 | 2019 | 63 | |
| 12 | 2018 | 62 | |
| 13 | 2019 | 58 | |
| 14 | 2018 | 37 | |
| 15 | 2019 | 29 | |
| 16 | 2018 | 29 | |
| 17 | 2019 | 26 | |
| 18 | 2021 | 25 | |
| 19 | 2020 | 25 | |
| 20 | 2019 | 24 |
About Hamzah Abu‐Sbeih
Hamzah Abu‐Sbeih is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 74 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Colorectal Cancer Treatments and Studies (27 papers), Microscopic Colitis (24 papers), Gastric Cancer Management and Outcomes (13 papers), Neutropenia and Cancer Infections (10 papers), Immune Cell Function and Interaction (7 papers), Clostridium difficile and Clostridium perfringens research (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Oncology (1.6k citations), Gastroenterology (108 citations), Epidemiology (673 citations), Immunology (387 citations) and Hepatology (125 citations). Hamzah Abu‐Sbeih has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Yinghong Wang, Faisal S. Ali, Wei Qiao, Gottumukkala S. Raju, Wenyi Luo, David M. Richards, Adi Diab, Phillip Lum, Tenglong Tang and Mehmet Altan. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Gastroenterology, Journal for ImmunoTherapy of Cancer, Gastroenterology and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.